Rinatabart sesutecan (Rina-S®) in advanced ovarian cancer and advanced or recurrent endometrial cancer: Results from dose-optimization cohorts in the phase 1/2 RAINFOL™-01 study

International Journal of Gynecological Cancer · Elsevier

Аннотация

Publication date: Available online 9 November 2026 Source: International Journal of Gynecological Cancer Author(s): Elizabeth K. Lee, Oladapo Yeku, Justin Call, Debra L. Richardson, Noelle Cloven, Andrea Jewell, Leigh Seamon, Lyndsay J. Willmott, Gottfried E. Konecny, Douglas Orr, Jessica Thomes Pepin, Xiaohua Wu, Ian Anderson, Joseph Buscema, Ramez N. Eskander, Cara Mathews, Anton Melnyk, Alexander Spira, Biyi Shen, Janelle Croissette

Читать у издателя →

Похожие статьи